Kirsten Wilbrand

Title: Kirsten Wilbrand: Innovator in Conjugated Estrogens

Introduction

Kirsten Wilbrand is a notable inventor based in Wunstorf, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the extraction and purification of conjugated estrogens. With a total of 2 patents, her work has advanced the understanding and application of natural hormone therapies.

Latest Patents

Kirsten's latest patents include a method for obtaining a natural mixture of conjugated equine estrogens. This innovative method involves solid-phase extraction from pregnant mares' urine, resulting in a product that is depleted of phenolic urine contents and non-conjugated lipophilic compounds. Another significant patent focuses on the separation of cresol from mares' urine using pervaporation with pore-free polymeric silicone membranes. This method provides high-quality conjugated estrogens while effectively reducing cresol content.

Career Highlights

Throughout her career, Kirsten has worked with prominent companies such as Abbott Products GmbH and Solvay Pharmaceuticals GmbH. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to the development of effective hormone therapies.

Collaborations

Kirsten has collaborated with notable professionals in her field, including Heinz-Helmer Rasche and Sabine Banschbach. These partnerships have fostered a collaborative environment that enhances research and development in the pharmaceutical industry.

Conclusion

Kirsten Wilbrand's contributions to the field of conjugated estrogens highlight her innovative spirit and dedication to advancing pharmaceutical science. Her patents and collaborations reflect her commitment to improving health outcomes through effective hormone therapies.